Moreover, our results also showed that several immune checkpoint genes, for example, CD47, TNFSF9 and PVR, were highly enriched in patients with high risk scores, which indicating that our prognostic model based on the four oxidative stress genes might be a guide for individualized immunotherapy for PAAD patients. The gene discussed is PVR; the disease is pancreatic adenocarcinoma.